Zobrazeno 1 - 10
of 10
pro vyhledávání: '"MC Donoso-Rengifo"'
Autor:
L Rendon-Lope, M Murillo-Izquierdo, E Alegre, MC Donoso-Rengifo, J Lopez-Santamaria, J Cordero Ramos
Publikováno v:
Eur J Hosp Pharm
Background At the moment the main treatment goals in Crohn’s desease (CD) are to induce and maintain remission, controlling inflammatory activity to keep the patient free of symptoms and avoid complications. Purpose To establish whether vedolizumab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd3a92eb6d53cd00d19bc7a6b16f50cc
https://doi.org/10.1136/ejhpharm-2018-eahpconf.506
https://doi.org/10.1136/ejhpharm-2018-eahpconf.506
Publikováno v:
Patient safety and risk management.
Background Linezolid is an antibiotic used to treat pneumonia and some infections of the skin or subcutaneous tissue. Purpose To describe the cohort of patients receiving outpatient treatment with oral linezolid in a tertiary hospital. Material and m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3311e6ca93c4e57236f2e9bda99dba59
https://doi.org/10.1136/ejhpharm-2017-000640.513
https://doi.org/10.1136/ejhpharm-2017-000640.513
Autor:
I Castañeda Macias, J Cordero Ramos, MC Donoso Rengifo, S Santana Martínez, M Murillo Izquierdo
Publikováno v:
Drug information and pharmacotherapy.
Background Idiopathic pulmonary fibrosis (IPF) is a specific type of chronic fibrosing interstitial pneumonia. Nintedanib is a tyrosine kinase inhibitor which has been approved for the clinical treatment of IPF in adults. Purpose To evaluate the effi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3727cc7d481d6431a300d3d12c64bfd
https://doi.org/10.1136/ejhpharm-2017-000640.259
https://doi.org/10.1136/ejhpharm-2017-000640.259
Publikováno v:
Pharmacokinetics and pharmacodynamics.
Background The strong degree of structural similarity between everolimus and sirolimus (SRL) causes cross reactivity between them. The underestimation observed with the everolimus quantitative microsphere system (QMS) led many centres to opt for the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfd4b61755f4b76d6c7c03e14bf88f5f
https://doi.org/10.1136/ejhpharm-2017-000640.446
https://doi.org/10.1136/ejhpharm-2017-000640.446
Publikováno v:
Drug information and pharmacotherapy.
Background Fampridine is indicated to improve walking in adult patients with multiple sclerosis (MS) and an expanded disability status scale (EDSS) score of 4–7. In order to evaluate continuation of treatment, there should be at least an improvemen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5dbced7a66b4f5d7b38370b7b0b296ce
https://doi.org/10.1136/ejhpharm-2017-000640.344
https://doi.org/10.1136/ejhpharm-2017-000640.344
Autor:
P Montejano-Hervás, MC Donoso Rengifo, A Gago-Sanchez, J López-Santamaria Donoso, I Reyes-Torres
Publikováno v:
European Journal of Hospital Pharmacy. 23:A98.3-A99
Background Eribulin is approved for use in pretreated metastatic breast cancer (MBC) patients after at least two chemotherapy regimens for advanced disease. Purpose To assess the effectiveness and safety of eribulin in MBC. Material and methods Retro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1904db324399ac9ac27827de6ecf7de7
https://doi.org/10.1136/ejhpharm-2016-000875.223
https://doi.org/10.1136/ejhpharm-2016-000875.223
Autor:
M Murillo Izquierdo, E Romero Carreño, MC Donoso Rengifo, Alvarado, S Santana Martínez, M. Martín
Publikováno v:
European Journal of Hospital Pharmacy. 23:A95.1-A95
Background Restricting the use of antibiotics at the hospital level is part of the rational use of these agents. Through a multidisciplinary process, their use is restricted to certain groups of patients or clinical situations to ensure greater effic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfd7d8a7b38f5765166814776e88002e
https://doi.org/10.1136/ejhpharm-2016-000875.215
https://doi.org/10.1136/ejhpharm-2016-000875.215
Autor:
Sara Santana, L Jiménez Guerrero, Alvarado Fernández, M Moya-Martin, MC Donoso Rengifo, M Vázquez-Real
Publikováno v:
European Journal of Hospital Pharmacy. 22:A178.2-A178
Background The cytostatic unit is a critical area in a hospital, therefore drug-related mistakes should be analysed in order to increase safety and effectiveness in patients treated with chemotherapy. Purpose To evaluate drug-related mistakes during
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::872ebf1a7639298d6e40bb029af3d20f
https://doi.org/10.1136/ejhpharm-2015-000639.429
https://doi.org/10.1136/ejhpharm-2015-000639.429
Autor:
A Maria Dolores, I Castañeda Macias, M Vázquez-Real, MC Donoso Rengifo, C Meneses Mangas, M Moya-Martin, Sara Santana
Publikováno v:
European Journal of Hospital Pharmacy. 22:A35.2-A35
Background Surgical patients are especially susceptible to nutritional disorders; additionally an adequate nutritional status is important in achieving prompt recovery. Purpose To describe and analyse possible shortcomings related to nutritional stat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2842ddbd750ec3046e9ea56aa77044c0
https://doi.org/10.1136/ejhpharm-2015-000639.84
https://doi.org/10.1136/ejhpharm-2015-000639.84
Autor:
Aumente MD; Hospital Universitario Reina Sofía, Unidad de farmacocinética, Servicio de Farmacia, Córdoba, Spain., López-Santamaría J, Donoso-Rengifo MC, Reyes-Torres I, Montejano Hervás P
Publikováno v:
Therapeutic drug monitoring [Ther Drug Monit] 2017 Oct; Vol. 39 (5), pp. 492-498.